| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 06/12/2007 | CA2130828C Non-azo naphthalimide dyes and uses for same |
| 06/07/2007 | WO2007064749A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | WO2007064732A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | WO2007064619A1 Pyrimidine derivatives as hiv integrase inhibitors |
| 06/07/2007 | WO2007064478A2 Method for making nicotine hapten |
| 06/07/2007 | WO2007064227A1 Multimeric magentic resonance contrast agents |
| 06/07/2007 | WO2007063934A1 Alicyclic heterocyclic compound |
| 06/07/2007 | WO2007063868A1 Arylmethylene urea derivative and use thereof |
| 06/07/2007 | WO2007063821A1 Acid addition salt of optically active dihydropyridine derivative |
| 06/07/2007 | WO2007063760A1 Organic compound, charge-transporting material, composition for charge-transporting material and organic electroluminescent device |
| 06/07/2007 | WO2007063013A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents |
| 06/07/2007 | WO2007063010A1 Novel vinylogous acids derivatives |
| 06/07/2007 | WO2007062999A2 1,5-substituted indol-2-yl amide derivatives |
| 06/07/2007 | WO2007062997A1 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators |
| 06/07/2007 | WO2007062996A1 3-amino-1-arylpropyl indoles and aza-substituted indoles |
| 06/07/2007 | WO2007062963A1 Oxime ester photoinitiators |
| 06/07/2007 | WO2007062817A1 Pyrrolidin(thi)ones heterocyclically substituted in 3-position |
| 06/07/2007 | WO2007062675A1 Method for producing metal salts of losartan |
| 06/07/2007 | WO2007057742A3 Novel piperazinone derivatives |
| 06/07/2007 | WO2007043677A9 Hydrazide compound and pesticidal use of the same |
| 06/07/2007 | WO2007043653A9 Benzimidazole-5-carboxamide derivative |
| 06/07/2007 | WO2007042786A3 4 -heteroaryl pyrimidine derivatives and use thereof as protein kinase inhibitors |
| 06/07/2007 | WO2007036533A3 Selected cgrp antagonists, a method for the production thereof and use in the form of drugs |
| 06/07/2007 | WO2007028132A3 6-N-LINKED HETEROCYCLE-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS |
| 06/07/2007 | WO2007024949A3 Alpha2c adrenoreceptor agonists |
| 06/07/2007 | WO2007014290A3 Fungicidal carboxamides |
| 06/07/2007 | WO2006084882A8 Substituted 4-(indol-3-yl)quinazolines and their use |
| 06/07/2007 | WO2006074147A3 Nitrogen containing bicyclic compounds and therapeutical use thereof |
| 06/07/2007 | US20070129551 Amidating trans-cotininecarboxylic acid to obtain of trans-cotinine amide; reducing to produce 3'-aminomethylnicotine |
| 06/07/2007 | US20070129539 Selective, tissue-specific TPO receptor agonists; thrombocytopenia resulting from radiation or chemotherapy; drug screening; [(N-substituted-2-oxo-1,2-dihydroindol-3-ylidene)hydrazino]-2-phenols; amyotrophic lateral sclerosis, multiple sclerosis, spinal cord injuries, muscular dystrophy |
| 06/07/2007 | US20070129421 Such as 3-[(5-Fluoro-3-methyl-1H-indol-2-yl)-phenyl-methyl]-4-hydroxy-5-isopropyl-1,5-dihydro-pyrrol-2-one which inhibits chymase |
| 06/07/2007 | US20070129414 Reacting1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one, 2-methyl imidazole the presence of an acid, an alkylsilylhalide compound or an acylhalide compound, in a solvent; used as an anti-vomiting agent |
| 06/07/2007 | US20070129407 Anthranilamides, process for the production thereof, and pest controllers containing the same |
| 06/07/2007 | US20070129406 Novel substituted sulfoxides |
| 06/07/2007 | US20070129405 Novel process for preparation of substituted sulfoxides |
| 06/07/2007 | US20070129404 kinase enzyme inhibitor 5-[4-(1-amino-1-methylethyl)phenyl]-1H-indazole, useful as a drug treating eye diseases including glaucoma |
| 06/07/2007 | US20070129400 Modulators of glucocorticoid receptor, AP-1, and/or NF-kB activity, and use thereof |
| 06/07/2007 | US20070129390 Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/07/2007 | US20070129387 Maleate salts of a quinazoline derivative useful as an antiangiogenic agent |
| 06/07/2007 | US20070129381 Pharmaceutically active pyrrolidine ester derivatives |
| 06/07/2007 | US20070129379 Hiv integrase inhibitors |
| 06/07/2007 | US20070129373 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 06/07/2007 | US20070129369 Heteroaryl substituted cyclohexyl-1,4-diamine compounds |
| 06/07/2007 | US20070129367 Pyridine derivatives as cb2 receptor modulators |
| 06/07/2007 | US20070129363 N-type calcium channel antagonists for the treatment of pain |
| 06/07/2007 | US20070129358 Sbstituted chroman derivatives, processes for their preparation and their use as antiinflammatory agents |
| 06/07/2007 | US20070129355 G-protein-coupled chemoattractant receptor, expressed on T helper cells antagonists such as [4-(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)-5-pyrimidinyl]acetic acid;, used for the treatment of allergic diseases, inflammatory diseases, eosinophil- and basophil-related diseases |
| 06/07/2007 | US20070129351 Novel processes for the preparation of cyclopropyl-amide derivatives |
| 06/07/2007 | US20070129346 Melanocortin receptor agonists |
| 06/07/2007 | US20070129338 Hydroxy-1-azobenzene derivative for treatment of thrombocytopenia |
| 06/07/2007 | US20070129335 T-type calcium channel blocker |
| 06/07/2007 | US20070128659 Hydrophilic labels for biomolecules |
| 06/07/2007 | US20070128115 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 06/07/2007 | CA2636314A1 Arylmethylene urea derivative and use thereof |
| 06/07/2007 | CA2632922A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | CA2632921A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | CA2632181A1 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use |
| 06/07/2007 | CA2631822A1 Acid addition salt of optically active dihydropyridine derivative |
| 06/07/2007 | CA2631232A1 Novel vinylogous acids derivatives |
| 06/07/2007 | CA2630410A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents |
| 06/07/2007 | CA2630314A1 1,5-substituted indol-2-yl amide derivatives |
| 06/07/2007 | CA2630307A1 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators |
| 06/07/2007 | CA2629962A1 3-amino-1-arylpropyl indoles and aza-substituted indoles |
| 06/07/2007 | CA2629143A1 Multimeric magentic resonance contrast agents |
| 06/07/2007 | CA2628817A1 Iminopropene compound and use thereof |
| 06/06/2007 | EP1792897A2 Intercalators having affinity for DNA and methods of use |
| 06/06/2007 | EP1791834A1 5-heterocyclyl pyrimidines |
| 06/06/2007 | EP1791832A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 06/06/2007 | EP1791831A2 Methods of treating diseases and disorders by targeting multiple kinases |
| 06/06/2007 | EP1791830A1 Diaminotriazole compounds useful as protein kinase inhibitors |
| 06/06/2007 | EP1791829A1 Heteroaroyl-substituted serine amides utilized as herbicides |
| 06/06/2007 | EP1791427A1 (hetero)cyclylcarboxamides for controlling pathogenic fungi |
| 06/06/2007 | EP1613313B1 2-phenyl-benzimidazol and 2-phenyl-imidazo-4,5]-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer |
| 06/06/2007 | DE102005057924A1 Pyridazinonderivate Pyridazinone derivatives |
| 06/06/2007 | CN1976926A Preparation of olmesartan medoxomil |
| 06/06/2007 | CN1976925A Prodrugs of pyrrolylpyrimidine ERK protein kinase inhibitors |
| 06/06/2007 | CN1976918A 4,5-disubstituted-2-aryl pyrimidines |
| 06/06/2007 | CN1976906A Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors |
| 06/06/2007 | CN1976905A Pyrimidine derivatives and methods of treatment related to the use thereof |
| 06/06/2007 | CN1976707A 3-aminocyclopentanecarboxamides as modulators of chemotactic factor receptors |
| 06/06/2007 | CN1976585A Substituted pyridazine carboxamides and derivatives thereof |
| 06/06/2007 | CN1974596A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 06/06/2007 | CN1320378C Filters for electronic displays |
| 06/06/2007 | CN1319968C Compositions useful as inhibitors of GSK-3 |
| 06/05/2007 | USRE39681 1-(4-sulfamyaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2 |
| 06/05/2007 | US7227026 Synthesis of a novel intermediate, 2-(1-trityl-1H-tetrazol-5-yl)phenylboronic acid, by combining 5-phenyl-1H-tetrazole with chlorotriphenylmethane and then reacting with a borate, both in basic solutions; a Suzuki coupling reaction with a protected imidazolephenylboronic acid will give irbesartan |
| 06/05/2007 | US7227025 Halogenation and oxidation of a 5-carboxyl-3-oxo-1-aryl-substituted-1H-pyrazolidine |
| 06/05/2007 | US7226940 Such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease |
| 06/05/2007 | US7226939 Thienopyridine analogues with antifungal activity and process thereof |
| 06/05/2007 | US7226929 drugs such as 6 -Chloro-N-{(3S)-1-[(1S)-1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide, used as antithrombotic agents |
| 06/05/2007 | US7226927 Administering 2-aryl-4- arylaminopyrimidine and analogs thereof, for therapy of disorder responsive to the induction of apoptosis in an animal suffering therefrom |
| 06/05/2007 | US7226925 Compounds, their use and preparation |
| 06/05/2007 | US7226923 Phthalazinone derivatives |
| 06/05/2007 | US7226920 Aminotriazole compounds useful as inhibitors of protein kinases |
| 06/05/2007 | CA2262847C Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2 |
| 05/31/2007 | WO2007062417A1 Methods of preparing 2-imidazol-1-yl-4-methyl-6-pyrrolidin-2-yl-pyrimidine and 4-(1-alkylpyrrolidin-2-yl)-2-(1h-imidazol-1-yl)-6-methylpyrimidine derivatives |
| 05/31/2007 | WO2007062342A1 Heterocyclic cetp inhibitors |
| 05/31/2007 | WO2007062318A2 Chemical compounds |
| 05/31/2007 | WO2007062193A1 Heterocycle-substituted 3-alkyl azetidine derivatives |
| 05/31/2007 | WO2007061454A1 Compositions comprising azelastine and methods of use thereof |